Reducing the maternal mortality rate due to postpartum haemorrhage depends on the ability of health-care teams to identify pregnant women at higher risk of bleeding, to timely and accurately detect ...

We thank Yutaka Shimazu for his constructive comments on our HD21 trial.1 In the PET-2 positive cohort, 165 (69%) of 240 patients treated with brentuximab vedotin, etoposide, cyclophosphamide, ...